As more and more credible evidence continues to emerge, the clinical application potential of the JAK2/STAT3 therapy has also gradually garnered significant attention in the treatment of chronic pain, such as osteoarthritis (OA) and tumor pain. This evidence concerns the gene STAT3 and neoplasm.